Skip to main navigation Skip to search Skip to main content

Synthesis, structural characterization and anticancer properties of p-cymene Ru(II) complexes with 2-(N-methyl-1H-1,2,4-triazol-3-yl)pyridines

  • Yulia M. Ohorodnik
  • , Sikalov A. Alexander
  • , Dmytro M. Khomenko
  • , Roman O. Doroshchuk
  • , Ilona V. Raspertova
  • , Sergiu Shova*
  • , Maria V. Babak
  • , Rostyslav D. Lampeka*
  • *Corresponding author for this work

Research output: Journal Publications and Reviews › RGC 21 - Publication in refereed journal › peer-review

Abstract

The structures of new p-cymene Ru(II) complexes with 2-(1-methyl-1H-1,2,4-triazol-3-yl)pyridine and 2-(1-methyl-1H-1,2,4-triazol-5-yl)pyridine were established based on the results of elemental analysis; IR and NMR spectra; and X-ray diffraction studies. Their anticancer activity, tested on human ovarian cancer cell lines A2780 (cisplatin-sensitive) and A2780cis (cisplatin-resistant), is also reported.
Original languageEnglish
Pages (from-to)213–221
JournalTransition Metal Chemistry
Volume47
Issue number6
Online published12 Jul 2022
DOIs
Publication statusPublished - Aug 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Synthesis, structural characterization and anticancer properties of p-cymene Ru(II) complexes with 2-(N-methyl-1H-1,2,4-triazol-3-yl)pyridines'. Together they form a unique fingerprint.

Cite this